News & Press Releases

Soley Therapeutics OG image.
June 8, 2026

Soley Therapeutics Appoints Berthil Clasen, PhD, MBA, as Chief Business Officer

Podcast
May 27, 2026

The Bio Report Podcast: Mapping Cellular Stress Biology to Tackle Undruggable Targets

Article
April 19, 2026

Technology Networks: Whole-Cell Stress Sensing: A New Lens for Cancer Drug Discovery

Soley Therapeutics OG image.
Press Release
April 17, 2026

Soley Therapeutics Presents Preclinical Data Demonstrating Selective Anti-Tumor Activity of STX-6398, a First-in-Class CKAP2 Modulator, at AACR 2026

Podcast
March 25, 2026

The BioHub Podcast: Episode 135 Yerem Yeghiazarians

Soley Therapeutics OG image.
Press Release
March 17, 2026

Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026

Article
March 3, 2026

Drug Discovery & Development: Can Live Cell Dynamics Fix Drug Discovery’s Efficacy Problem?

Article
February 24, 2026

Drug Discovery Online: A State of Stress: Developing Therapeutics Rooted in Cell Behavior

Soley Therapeutics OG image.
Press Release
January 21, 2026

Soley Therapeutics Announces Breakthrough Research Demonstrating How Cellular Stress Responses Reveal Drug Mechanisms, Enabling Entirely New and Accelerated Methods for Drug Discovery

Article
January 13, 2026

BioXconomy: Stress Relief for Cells as Soley Lands $200m Series C Funding

Publication
January 8, 2026

A self-supervised machine learning pipeline for extracting information from live cell images at multiple doses and timepoints

Article
January 7, 2026

FirstWord Pharma Top Story: Soley’s $200M to Pursue Drug Development Based on Cellular Stress Sensing

Article
January 7, 2026

Fierce Biotech: Soley Secures $200M Series C to Push AML Cell Stress Drug into Clinic

Soley Therapeutics OG image.
Press Release
January 7, 2026

Soley Therapeutics Announces $200 Million Series C Financing to Propel Lead Oncology Programs into the Clinic and Scale Its Cell Stress Sensing Platform

Article
January 7, 2026

Endpoints Exclusive: Soley Emerges with $200M Series C and Broad Pipeline for ‘Stress Clock’

Soley Therapeutics OG image.
Press Release
March 22, 2025

Oracle and NVIDIA Collaborate to Help Enterprises Accelerate Agentic AI Inference

Soley Therapeutics OG image.
Press Release
March 22, 2025

Soley Therapeutics and Oracle Collaborate to Advance AI-Driven Drug Discovery

Publication
September 22, 2021

Interleukin-15 Modulates the Response of Cortical Neurons to Ischemia

Publication
May 22, 2021

A Novel Pro-survival Signaling Pathway in Cardiomyocytes

Publication
January 22, 2020

Administration of Interleukin-15 Peptide Improves Cardiac Function in a Mouse Model of Myocardial Infarction

Publication
December 22, 2015

Encyclopedia of Cancer: Anoxia

Publication
February 10, 2015

HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity During Glucose Deprivation to Modulate Cell Survival and Tumor Growth

Publication
April 8, 2013

Nuclear Localization of the Mitochondrial Factor HIGD1A during Metabolic Stress

Publication
January 5, 2010

Circulating Tumour Cells Demonstrate an Altered Response to Hypoxia and an Aggressive Phenotype

Publication
July 17, 2009

Injection of Bone Marrow Cell Extract Into Infarcted Hearts Results in Functional Improvement Comparable to Intact Cell Therapy

Publication
January 11, 2007

Induction of Activating Transcription Factor 3 by Anoxia Is Independent of p53 and the Hypoxic HIF Signalling Pathway

Publication
March 1, 2004

Anoxic Induction of ATF-4 through HIF-1-Independent Pathways of Protein Stabilization in Human Cancer Cells

Publication
October 29, 2002

Regulation of a Rat VL30 Element in Human Breast Cancer Cells in Hypoxia and Anoxia: Role of HIF-1

Stay Updated

Subscribe to receive the latest news and updates from Soley Therapeutics